1. Início
  2. Faculdade de Medicina - FM
  3. Departamento de Clínica Médica - FM/MCM
  4. Artigos e Materiais de Revistas Científicas - FM/MCM
Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/413
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorMEDEIROS-NETO, Geraldo-
dc.contributor.authorCAMARGO, Rosalinda Y.-
dc.contributor.authorTOMIMORI, Eduardo K.-
dc.date.accessioned2013-07-30T14:41:42Z-
dc.date.available2013-07-30T14:41:42Z-
dc.date.issued2012-
dc.identifier.citationMEDICAL CLINICS OF NORTH AMERICA, v.96, n.2, p.351-0, 2012-
dc.identifier.issn0025-7125-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/413-
dc.description.abstractThe main causes of simple diffuse goiter (SDG) and multinodular goiter (MNG) are iodine deficiency, increase in serum thyroid-stimulating hormone (TSH) level, natural goitrogens, smoking, chronic malnutrition, and lack of selenium, iron, and zinc. Increasing evidence suggests that heredity is equally important. Treatment of SDG and MNG still focuses on L-thyroxine-suppressive therapy surgery. Radioiodine alone or preceded by recombinant human TSH stimulation is widely used in Europe and other countries. Each of these therapeutic options has advantages and disadvantages, with acute and long-term side effects.-
dc.description.sponsorshipInstituto da Tiroide-Sao Paulo, Brazil-
dc.language.isoeng-
dc.publisherW B SAUNDERS CO-ELSEVIER INC-
dc.relation.ispartofMedical Clinics of North America-
dc.rightsrestrictedAccess-
dc.subjectSimple goiter-
dc.subjectMultinodular goiter-
dc.subjectSonography-
dc.subjectSurgery-
dc.subjectL-thyroxine therapy-
dc.subjectRadioiodine ablation-
dc.subject.otherrecombinant human thyrotropin-
dc.subject.othernontoxic multinodular goiter-
dc.subject.otherlevothyroxine suppressive therapy-
dc.subject.otherfamilial euthyroid goiter-
dc.subject.othernon-toxic goiter-
dc.subject.othernodular goiter-
dc.subject.otherradioiodine therapy-
dc.subject.otherhuman tsh-
dc.subject.otherthyroid-nodules-
dc.subject.otherdouble-blind-
dc.titleApproach to and Treatment of Goiters-
dc.typearticle-
dc.rights.holderCopyright W B SAUNDERS CO-ELSEVIER INC-
dc.identifier.doi10.1016/j.mcna.2012.01.010-
dc.identifier.pmid22443980-
dc.subject.wosMedicine, General & Internal-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage351-
hcfmusp.description.endpage0-
hcfmusp.description.issue2-
hcfmusp.description.volume96-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84858761169-
hcfmusp.origem.idWOS:000303282000013-
hcfmusp.publisher.cityPHILADELPHIA-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAbdel Rahim AA, 1999, BRIT J SURG, V86, P88, DOI 10.1046/j.1365-2168.1999.00978.x-
hcfmusp.relation.referenceAlbayrak Y, 2011, MINERVA CHIR, V66, P189-
hcfmusp.relation.referenceBahn RS, 2011, J CLIN ENDOCR METAB, V96, P1202, DOI 10.1210/jc.2010-2583-
hcfmusp.relation.referenceBayer Y, 2004, J CLIN ENDOCR METAB, V89, P4044, DOI 10.1210/jc.2003-032096-
hcfmusp.relation.referenceBERGHOUT A, 1989, CLIN ENDOCRINOL, V31, P193, DOI 10.1111/j.1365-2265.1989.tb01242.x-
hcfmusp.relation.referenceBERGHOUT A, 1990, AM J MED, V89, P602, DOI 10.1016/0002-9343(90)90178-G-
hcfmusp.relation.referenceBignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610-
hcfmusp.relation.referenceBonnema SJ, 2002, J CLIN ENDOCR METAB, V87, P112, DOI 10.1210/jc.87.1.112-
hcfmusp.relation.referenceBonnema SJ, 2007, J CLIN ENDOCR METAB, V92, P3424, DOI 10.1210/jc.2007-0501-
hcfmusp.relation.referenceBonnema SJ, 2000, CLIN ENDOCRINOL, V53, P5, DOI 10.1046/j.1365-2265.2000.01060.x-
hcfmusp.relation.referenceBonnema SJ, 2009, CURR OPIN ENDOCRINOL, V16, P379, DOI 10.1097/MED.0b013e32832ff2e1-
hcfmusp.relation.referenceBrauer VFH, 2006, EUR J ENDOCRINOL, V155, P807, DOI 10.1530/eje.1.02302-
hcfmusp.relation.referenceBraverman LE, 2007, THYROID, V17, P819, DOI 10.1089/thy.2007.0105-
hcfmusp.relation.referenceBrix TH, 2000, ANN MED, V32, P153, DOI 10.3109/07853890008998821-
hcfmusp.relation.referenceBrix TH, 1999, J CLIN ENDOCR METAB, V84, P3071, DOI 10.1210/jc.84.9.3071-
hcfmusp.relation.referenceBrucker-Davis F, 2003, ENCY HORMONES, P535-
hcfmusp.relation.referenceCannon C Ron, 2010, J Miss State Med Assoc, V51, P179-
hcfmusp.relation.referenceCapon F, 2000, AM J HUM GENET, V67, P1004, DOI 10.1086/303095-
hcfmusp.relation.referenceCeccarelli C, 2010, MINERVA ENDOCRINOL, V35, P161-
hcfmusp.relation.referenceCeccarelli C, 2011, THYROID, V21, P759, DOI 10.1089/thy.2010.0088-
hcfmusp.relation.referenceCesareo R, 2010, ENDOCR J, V57, P803-
hcfmusp.relation.referenceCorral M, 1993, LANCET, V341, P462-
hcfmusp.relation.referenceCubas ER, 2009, INT J CLIN PRACT, V63, P583, DOI 10.1111/j.1742-1241.2008.01904.x-
hcfmusp.relation.referenceDelange F, 1997, EUR J ENDOCRINOL, V136, P180-
hcfmusp.relation.referenceDoerge DR, 2002, J CHROMATOGR B, V777, P269, DOI 10.1016/S1570-0232(02)00214-3-
hcfmusp.relation.referenceDogan L, 2011, SURG TODAY, V41, P323, DOI 10.1007/s00595-009-4272-6-
hcfmusp.relation.referenceFast S, 2009, EUR J ENDOCRINOL, V160, P517, DOI 10.1530/EJE-08-0779-
hcfmusp.relation.referenceFast S, 2010, CLIN ENDOCRINOL, V72, P411, DOI 10.1111/j.1365-2265.2009.03650.x-
hcfmusp.relation.referenceFast S, 2009, J NUCL MED, V50, P732, DOI 10.2967/jnumed.108.060152-
hcfmusp.relation.referenceFast S, 2011, ANN ENDOCRINOL-PARIS, V72, P129, DOI 10.1016/j.ando.2011.03.018-
hcfmusp.relation.referenceFast S, 2010, RECOMBINANT HUMAN TS-
hcfmusp.relation.referenceGAITAN E, 1994, EUR J ENDOCRINOL, V131, P138-
hcfmusp.relation.referenceGAITAN E, 1993, THYROID, V3, P49, DOI 10.1089/thy.1993.3.49-
hcfmusp.relation.referenceGonzalez-Sarmiento R, 2001, THYROID, V11, P789, DOI 10.1089/10507250152484655-
hcfmusp.relation.referenceGraf H, 2011, J CLIN ENDOCR METAB, V96, P1368, DOI 10.1210/jc.2010-1193-
hcfmusp.relation.referenceGrussendorf M, 2011, J CLIN ENDOCR METAB, V96, P2786, DOI 10.1210/jc.2011-0356-
hcfmusp.relation.referenceGullu S, 1999, ENDOCR J, V46, P221, DOI 10.1507/endocrj.46.221-
hcfmusp.relation.referenceHegedus L, 2009, NAT REV ENDOCRINOL, V5, P476, DOI 10.1038/nrendo.2009.152-
hcfmusp.relation.referenceHegedus L, 2003, ENDOCR REV, V24, P102, DOI 10.1210/er.2002-0016-
hcfmusp.relation.referenceHEGEDUS L, 1988, BRIT MED J, V297, P661-
hcfmusp.relation.referenceHegedus L, 1999, J CLIN ENDOCR METAB, V84, P756, DOI 10.1210/jc.84.2.756-
hcfmusp.relation.referenceHegedus L, 2009, THYROID, V19, P209, DOI 10.1089/thy.2009.0047-
hcfmusp.relation.referenceHegedus L, 2010, ENDOCRINOLOGY, P1636-
hcfmusp.relation.referenceHussain M, 2008, ASIAN J SURG, V31, P59, DOI 10.1016/S1015-9584(08)60059-7-
hcfmusp.relation.referenceIngenbleek Y, 1983, Experientia Suppl, V44, P264-
hcfmusp.relation.referenceKralik A, 1996, HORM METAB RES, V28, P223, DOI 10.1055/s-2007-979169-
hcfmusp.relation.referenceKrohn K, 2000, J PATHOL, V192, P37, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH650>3.3.CO;2-V-
hcfmusp.relation.referenceKrohn K, 2005, ENDOCR REV, V26, P504, DOI 10.1210/er.2004-0005-
hcfmusp.relation.referenceLaurberg P, 2004, J CLIN ENDOCR METAB, V89, P181, DOI 10.1210/jc.2003-030829-
hcfmusp.relation.referenceLima N, 1997, THYROID, V7, P691, DOI 10.1089/thy.1997.7.691-
hcfmusp.relation.referenceLINDSAY RH, 1992, J TOXICOL ENV HEALTH, V37, P467-
hcfmusp.relation.referenceMedeiros-Neto G, 2010, MULTIMODULAR GOITER-
hcfmusp.relation.referenceMedeiros-Neto G, 2008, ENDOCRINE, V33, P109, DOI 10.1007/s12020-008-9077-7-
hcfmusp.relation.referenceMedeirosNeto G, 1996, ENDOCRINOLOGIST, V6, P353-
hcfmusp.relation.referenceMerke F, 1974, HIST ICONOGRAPHY END-
hcfmusp.relation.referenceMICCOLI P, 1993, SURGERY, V114, P1097-
hcfmusp.relation.referenceMiccoli P, 1993, SURGERY, V114, P1097-
hcfmusp.relation.referenceNeumann S, 1999, J CLIN ENDOCR METAB, V84, P3750, DOI 10.1210/jc.84.10.3750-
hcfmusp.relation.referenceNgan ESW, 2009, J NATL CANCER I, V101, P162, DOI 10.1093/jnci/djn471-
hcfmusp.relation.referenceNgudi DD, 2003, FOOD CHEM TOXICOL, V41, P1193, DOI 10.1016/S0278-6915(03)00111-X-
hcfmusp.relation.referenceNielsen VE, 2006, ARCH INTERN MED, V166, P1476, DOI 10.1001/archinte.166.14.1476-
hcfmusp.relation.referencePapini E, 1998, J CLIN ENDOCR METAB, V83, P780, DOI 10.1210/jc.83.3.780-
hcfmusp.relation.referencePardo V, 2009, J CLIN ENDOCR METAB, V94, P2938, DOI 10.1210/jc.2009-0150-
hcfmusp.relation.referenceRiju R, 2009, J Indian Med Assoc, V107, P223-
hcfmusp.relation.referenceROJDMARK J, 1995, EUR J SURG, V161, P725-
hcfmusp.relation.referenceRomao R, 2009, THYROID, V19, P945, DOI 10.1089/thy.2008.0394-
hcfmusp.relation.referenceRubio IGS, 2009, CURR OPIN ENDOCRINOL, V16, P373, DOI 10.1097/MED.0b013e32832ff218-
hcfmusp.relation.referenceRuz M, 1999, J NUTR, V129, P174-
hcfmusp.relation.referenceSamuels MH, 2001, J CLIN ENDOCR METAB, V86, P994, DOI 10.1210/jc.86.3.994-
hcfmusp.relation.referenceSchroder-van der Elst JP, 2003, BIOFACTORS, V19, P171-
hcfmusp.relation.referenceSilva MNC, 2004, CLIN ENDOCRINOL, V60, P300, DOI 10.1046/j.1365-2265.2003.01918.x-
hcfmusp.relation.referenceSTUDER H, 1989, ENDOCR REV, V10, P125-
hcfmusp.relation.referenceSUZUKI H, 1965, ACTA ENDOCRINOL-COP, V50, P161-
hcfmusp.relation.referenceTakahashi Tsutomu, 2001, Biochemical and Biophysical Research Communications, V284, P650, DOI 10.1006/bbrc.2001.4998-
hcfmusp.relation.referenceTORRE G, 1995, AM SURGEON, V61, P826-
hcfmusp.relation.referenceTurbridge WM, 1977, CLIN ENDOCRINOL, V7, P481-
hcfmusp.relation.referenceVadasz P, 1998, EUR J CARDIO-THORAC, V14, P393, DOI 10.1016/S1010-7940(98)00204-8-
hcfmusp.relation.referenceVANDER JB, 1954, NEW ENGL J MED, V251, P970, DOI 10.1056/NEJM195412092512403-
hcfmusp.relation.referenceWADA L, 1986, J NUTR, V116, P1045-
hcfmusp.relation.referenceWesche MFT, 2001, J CLIN ENDOCR METAB, V86, P998, DOI 10.1210/jc.86.3.998-
hcfmusp.relation.referenceZelmanovitz F, 1998, J CLIN ENDOCR METAB, V83, P3881, DOI 10.1210/jc.83.11.3881-
hcfmusp.relation.referenceZimmermann MB, 2007, AM J CLIN NUTR, V86, P1040-
hcfmusp.relation.referenceZimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3-
hcfmusp.relation.referenceZimmermann MB, 2006, ANNU REV NUTR, V26, P367, DOI 10.1146/annurev.nutr.26.061505.111236-
dc.description.indexMEDLINE-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus21-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/25
LIM/25 - Laboratório de Endocrinologia Celular e Molecular


Files in This Item:
File Description SizeFormat 
art_MEDEIROS-NETO_Approach_to_and_Treatment_of_Goiters_2012.PDF
  Restricted Access		publishedVersion (English)555.62 kBAdobe PDFView/Open Request a copy
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.